MedTrace Logo

RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.

NCT00539565 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-10-04

No results posted yet for this study

Summary

Biliary atresia is a congenital disorder of bile duct development or destruction of established but immature bile ducts. The study tests the hypothesis that post-operative steroids improve outcome following the Kasai procedure - the commonest surgical treatment.

Conditions

  • Biliary Atresia

Interventions

DRUG

prednisolone

2 mg/kg /day from post-op day 7 - day 21 1 mg/kg /day from post-op day 22 - day 30

DRUG

placebo

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    lead OTHER

Principal Investigators

  • Mark Davenport, ChM · Kings College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
100 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Completion
2008-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00539565 on ClinicalTrials.gov